Light can be used to consolidate sleep in individuals with Alzheimer’s disease and related dementias, but the light delivery method is one of the greatest challenges for successful treatment. Based on our field observations, it was hypothesised that a self-luminous light table would be a practical way to deliver light because persons with Alzheimer’s disease typically spend a significant amount of time sitting at tables. Compared to a baseline week, sleep percent and efficiency significantly increased and agitation and depression scores significantly decreased during the four intervention weeks. The self-luminous light table was an effective and practical method to deliver circadian-effective light to persons with Alzheimer’s disease.
Get full access to this article
View all access options for this article.
References
1.
MishimaKHishikawaYOkawaM. Randomized, dim light controlled, crossover test of morning bright light therapy for rest-activity rhythm disorders in patients with vascular dementia and dementia of Alzheimer’s type. Chronobiology International1998; 15: 647–654.
2.
LyketsosCLindell VeielLBakerASteeleC. A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long-term care. International Journal of Geriatric Psychiatry1999; 14: 520–525.
3.
YamaderaHItoTSuzukiHAsayamaKItoREndoS. Effects of bright light on cognitive and sleep–wake (circadian) rhythm disturbances in Alzheimer-type dementia. Psychiatry and Clinical Neurosciences2000; 54: 352–353.
4.
Van SomerenEJWKesslerAMirmirannMSwaabDF. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biological Psychiatry1997; 41: 955–963.
5.
ColendaCCCohenWMcCallWVRosenquistPB. Phototherapy for patients with Alzheimer disease with disturbed sleep patterns: results of a community-based pilot study. Alzheimer Disease and Associated Disorders1997; 11: 175–178.
6.
ForbesDBlakeCMThiessenEJPeacockSHawranikP. Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia. The Cochrane Database of Systematic Reviews2014; 2: CD003946–CD003946.
7.
World Medical Association. Declaration of Helsinki. JAMA2000; 284: 3043–3045.
8.
ReaMSFigueiroMGBulloughJDBiermanA. A model of phototransduction by the human circadian system. Brain Research Reviews2005; 50: 213–228.
9.
ReaMSFigueiroMGBiermanAHamnerR. Modeling the spectral sensitivity of the human circadian system. Lighting Research and Technology2012; 44: 386–396.
10.
ReaMSFigueiroMGBiermanABulloughJD. Circadian light. Journal of Circadian Rhythms2010; 8: 2–2.
11.
FigueiroMGHamnerRBiermanAReaMS. Comparisons of three practical field devices used to measure personal light exposures and activity levels. Lighting Research and Technology2013; 45: 421–434.
12.
BuysseDJReynoldsCFMonkTHBermanSRKupferDJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Research1989; 28: 193–213.
13.
AlexopolousGSAbramsRCYoungRCShamoianCA. Cornell Scale for Depression in Dementia. Biological Psychiatry1988; 23: 271–271.
14.
Cohen-MansfieldJMarxMSRosenthalAS. A description of agitation in a nursing home. The Journals of Gerontology1989; 44: M77–M84.
15.
FigueiroMGPlitnickBLokAJonesGHigginsPHornickTReaMS. Tailored lighting intervention improves measures of sleep, depression and agitation in persons with Alzheimer’s disease and related dementia living in long-term care facilities. Journal of Clinical Interventions in Aging2014; 9: 1527–1537.
16.
Van SomerenEJWHagebeukEELijzengaCScheltensPde RooijSEJonkerCPotAMMirmiranMSwaabDF. Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biological Psychiatry1996; 40: 259–270.
17.
Riemersma-van der LekRFSwaabDFTwiskJHolEMHoogendijkWJVan SomerenEJ. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA2008; 299: 2642–2655.
18.
KangJ-ELimMMBatemanRJLeeJJSmythLPCirritoJRFujikiNNishinoSHoltzmanDM. Amyloid-β dynamics are regulated by orexin and the sleep-wake cycle. Science2009; 326: 1005–1007.
19.
SpiraAPGamaldoAAAnYWuMNSimonsickEMBilgelMZhouYWongDFFerrucciLResnickSM. Self-reported sleep and β-amyloid deposition in community-dwelling older adults. JAMA Neurology2013; 70: 1537–1543.
20.
Spira AP, Yager C, Brandt J, Smith GS, Zhou Y, Mathur A, Kumar A, Brašić JR, Wong DF, Wu MN. Objectively measured sleep and β-amyloid burden in older adults: A pilot study. SAGE Open Medicine 2014; 2: 1–6. DOI: 10.1177/2050312114546520.
